IDEAS home Printed from https://ideas.repec.org/p/zbw/grewdp/042001.html

Managed competition in health care in the Netherlands and Germany: Theoretical foundation, empirical findings and policy conclusions

Author

Listed:
  • Greß, Stefan
  • Okma, Kieke
  • Hessel, Franz

Abstract

No abstract is available for this item.

Suggested Citation

  • Greß, Stefan & Okma, Kieke & Hessel, Franz, 2001. "Managed competition in health care in the Netherlands and Germany: Theoretical foundation, empirical findings and policy conclusions," Wirtschaftswissenschaftliche Diskussionspapiere 04/2001, University of Greifswald, Faculty of Law and Economics.
    • Handle: RePEc:zbw:grewdp:042001
    as

    Download full text from publisher

    File URL: https://www.econstor.eu/bitstream/10419/48936/1/331075091.pdf
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Kroneman, Madelon W. & van der Zee, Jouke, 1997. "Health policy as a fuzzy concept: Methodological problems encountered when evaluating health policy reforms in an international perspective," Health Policy, Elsevier, vol. 40(2), pages 139-155, May.
    2. Lamers, Leida M., 1998. "Risk-adjusted capitation payments: Developing a diagnostic cost groups classification for the Dutch situation," Health Policy, Elsevier, vol. 45(1), pages 15-32, July.
    3. Joan Robinson, 1954. "The Impossibility of Competition," International Economic Association Series, in: Edward H. Chamberlin (ed.), Monopoly and Competition and their Regulation, pages 245-254, Palgrave Macmillan.
    4. van Barneveld, Erik M. & Lamers, Leida M. & van Vliet, Rene C. J. A. & van de Ven, Wynand P. M. M., 2001. "Risk sharing as a supplement to imperfect capitation: a tradeoff between selection and efficiency," Journal of Health Economics, Elsevier, vol. 20(2), pages 147-168, March.
    5. Schut, Frederik T. & van Doorslaer, Eddy K. A., 1999. "Towards a reinforced agency role of health insurers in Belgium and the Netherlands," Health Policy, Elsevier, vol. 48(1), pages 47-67, July.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Kumpmann, Ingmar, 2009. "Monopolistic Competition and Costs in the Health Care Sector," IWH Discussion Papers 17/2009, Halle Institute for Economic Research (IWH).
    2. Greß, Stefan & Okma, Kieke G. H. & Wasem, Jürgen, 2002. "Private health insurance in social health insurance countries: Market outcomes and policy implications," Wirtschaftswissenschaftliche Diskussionspapiere 01/2002, University of Greifswald, Faculty of Law and Economics.
    3. Stefan Greß & Diana Delnoij & Peter Groenewegen, 2003. "Exit and Voice in Dutch Social Health Insurance," ifo DICE Report, ifo Institute - Leibniz Institute for Economic Research at the University of Munich, vol. 1(3), pages 47-53, 02.
    4. Gulácsi, László & Kovács, Erzsébet & Oesterle, August & Boncz, Imre, 2007. "Verseny az egészségügyben. Egyesült államokbeli és nyugat-európai példák [Competition in health care. US and West European examples]," Közgazdasági Szemle (Economic Review - monthly of the Hungarian Academy of Sciences), Közgazdasági Szemle Alapítvány (Economic Review Foundation), vol. 0(5), pages 480-498.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Stam, Pieter J.A. & van Vliet, René C.J.A. & van de Ven, Wynand P.M.M., 2010. "A limited-sample benchmark approach to assess and improve the performance of risk equalization models," Journal of Health Economics, Elsevier, vol. 29(3), pages 426-437, May.
    2. Richard C. van Kleef, 2012. "Managed competition in the Dutch Health Care System: Preconditions and experiences so far," Public Policy Review, Policy Research Institute, Ministry of Finance Japan, vol. 8(2), pages 145-170, July.
    3. Timothy J. Layton & Randall P. Ellis & Thomas G. McGuire, 2015. "Assessing Incentives for Adverse Selection in Health Plan Payment Systems," Boston University - Department of Economics - Working Papers Series wp2015-024, Boston University - Department of Economics.
    4. Mathias Kifmann & Normann Lorenz, 2011. "Optimal cost reimbursement of health insurers to reduce risk selection," Health Economics, John Wiley & Sons, Ltd., vol. 20(5), pages 532-552, May.
    5. √Ålvaro Riascos & Eduardo Alfonso & Mauricio Romero, 2014. "The Performance of Risk Adjustment Models in Colombian Competitive Health Insurance Market," Documentos CEDE 12062, Universidad de los Andes, Facultad de Economía, CEDE.
    6. Richard C van Kleef & Konstantin Beck & Florian Buchner, 2010. "Risk-Type Concentration and Efficiency Incentives: A Challenge for the Risk Adjustment Formula," The Geneva Papers on Risk and Insurance - Issues and Practice, Palgrave Macmillan;The Geneva Association, vol. 35(4), pages 503-520, October.
    7. Eugster, Patrick & Sennhauser, Michèle & Zweifel, Peter, 2010. "Capping risk adjustment?," Journal of Health Economics, Elsevier, vol. 29(4), pages 499-507, July.
    8. Maarse, Hans & Paulus, Aggie & Kuiper, Gerard, 2005. "Supervision in social health insurance: a four country study," Health Policy, Elsevier, vol. 71(3), pages 333-346, March.
    9. Lamers, Leida M. & van Vliet, Rene C. J. A., 2004. "The Pharmacy-based Cost Group model: validating and adjusting the classification of medications for chronic conditions to the Dutch situation," Health Policy, Elsevier, vol. 68(1), pages 113-121, April.
    10. J. E. King, 2000. "Introduction to an Unpublished Note by Nicholas Kaldor & Joan Robinson," Review of Political Economy, Taylor & Francis Journals, vol. 12(3), pages 261-265.
    11. Schokkaert, Erik & Van de Voorde, Carine, 2003. "Belgium: risk adjustment and financial responsibility in a centralised system," Health Policy, Elsevier, vol. 65(1), pages 5-19, July.
    12. Gre[ss], Stefan & Groenewegen, Peter & Kerssens, Jan & Braun, Bernard & Wasem, Juergen, 2002. "Free choice of sickness funds in regulated competition: evidence from Germany and The Netherlands," Health Policy, Elsevier, vol. 60(3), pages 235-254, June.
    13. Gross, Revital & Rosen, Bruce & Chinitz, David, 1998. "Evaluating the Israeli health care reform: strategy, challenges and lessons," Health Policy, Elsevier, vol. 45(2), pages 99-117, August.
    14. van Kleef, R.C. & van Vliet, R.C.J.A. & van Rooijen, E.M., 2014. "Diagnoses-based cost groups in the Dutch risk-equalization model: The effects of including outpatient diagnoses," Health Policy, Elsevier, vol. 115(1), pages 52-59.
    15. Pavel Sorokin, 2018. "Making Global Sociology in the Context of Neoliberal Domination: Challenges, Ideology and Possible Strategies," Sociological Research Online, , vol. 23(1), pages 21-42, March.
    16. Eijkenaar, Frank & van Vliet, René C.J.A., 2017. "Improving risk equalization for individuals with persistently high costs: Experiences from the Netherlands," Health Policy, Elsevier, vol. 121(11), pages 1169-1176.
    17. Francesco Paolucci & Amir Shmueli, 2011. "The Introduction of Ex-ante Risk Equalisation in the Australian Private Health Insurance Market: A First Step," Agenda - A Journal of Policy Analysis and Reform, Australian National University, College of Business and Economics, School of Economics, vol. 18(2), pages 71-92.
    18. Pieter Bakx & Frederik Schut & Eddy Doorslaer, 2015. "Can universal access and competition in long-term care insurance be combined?," International Journal of Health Economics and Management, Springer, vol. 15(2), pages 185-213, June.
    19. Gonzalez Block, Miguel Angel, 1997. "Comparative research and analysis methods for shared learning from health system reforms," Health Policy, Elsevier, vol. 42(3), pages 187-209, December.
    20. van Barneveld, Erik M. & Lamers, Leida M. & van Vliet, Rene C. J. A. & van de Ven, Wynand P. M. M., 2001. "Risk sharing as a supplement to imperfect capitation: a tradeoff between selection and efficiency," Journal of Health Economics, Elsevier, vol. 20(2), pages 147-168, March.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:zbw:grewdp:042001. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: ZBW - Leibniz Information Centre for Economics (email available below). General contact details of provider: https://edirc.repec.org/data/wwgrede.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.